| Title: |
Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC) |
| Authors: |
Plummer, R.; Cook, N.; Arkenau, T.; Melear, J.; Redfern, C.; Spira, A.I.; Chung, K.; Haddad, T.; Ramalingam, S.S.; Wesolowski, R.; Dean, E.; Goddemeier, T.; Falk, M.; Shapiro, G. |
| Source: |
Annals of Oncology ; volume 29, page viii519 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2018 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/annonc/mdy292.059 |
| Availability: |
http://dx.doi.org/10.1093/annonc/mdy292.059; https://api.elsevier.com/content/article/PII:S0923753419498499?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753419498499?httpAccept=text/plain; http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy292.059/26141426/mdy292.059.pdf |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.E9630B5B |
| Database: |
BASE |